Every few years, the technology industry has a moment where its most senior voices, people who genuinely do not need the attention, all start saying the same thing at once. We are in one of those moments now, and it is about AI agents.
At CES 2025, Nvidia founder and CEO Jensen Huang told a packed keynote hall that the industry was entering the age of AI Agentics, describing systems that can perceive a situation, reason about it, plan a response, and act, inside a real workflow, not a chat window. He called it a multi trillion dollar opportunity. [1]
A few months later, OpenAI’s Sam Altman published an essay called The Gentle Singularity. Buried inside the bigger claims about superintelligence was a smaller, more practical one: 2025, he wrote, was the year agents capable of real cognitive work arrived, systems that do not just answer a question but carry a task through to completion. [2]
Different companies, different incentives, same underlying point. The raw intelligence inside an AI model is becoming a commodity. Anyone can buy access to a good model. What is hard, and what is valuable, is building something that takes that intelligence and actually finishes the job, end to end, inside a process someone is accountable for.
Why this is not just industry noise
It would be easy to file this under AI hype and move on. But the distinction Huang and Altman are both pointing at, between a model that answers and an agent that acts, is exactly the distinction that separates a diagnostic tool from a system an organisation can actually rely on to manage risk.
A model tells you something. An agent does something about it, and then shows its working. That second part, the doing and the showing, is where the real cost of workforce risk actually gets managed, and it is where we built ALIGN.R3 to operate from day one.
What that looks like inside ALIGN.R3
ALIGN.R3 was never designed as a survey with a score at the end. The Biomechanical Alignment Index, BAI™, is the starting point, not the destination. It takes a structured set of inputs from every employee, regardless of role, desk-based or frontline, office or depot, and turns that into an individual risk profile.
From there, the platform does the part a static score cannot do on its own. It generates MicroMovements™, individualised, evidence-based physical interventions, matched to that person’s specific risk profile, requiring nothing beyond what is already in their workplace. That output is produced by the platform, not handed to a clinician or a line manager to work out.
That is the loop. Risk identified, intervention generated, outcome accounted for. Not a score in a dashboard. A system that acts, and then proves it.
The results then roll up into an organisational Alignment Score and a statutory evidence pack, the kind of board-ready reporting a Finance Director or Section 151 Officer can actually use to demonstrate that a known, costly risk is being managed under the Health and Safety at Work etc. Act 1974 and the Management of Health and Safety at Work Regulations 1999.
The question worth asking of any AI investment
If the people building the world’s most advanced AI systems are right, and value really is moving from the model to the agent, then the right question to ask of any AI-branded product is not whether it uses AI. Almost everything claims that now. The right question is whether it closes the loop, whether it takes a real problem through to a completed, accountable outcome, or whether it stops at a number and leaves the hard part to someone else.
For UK councils and commercial employers carrying the cost of musculoskeletal absence, currently the largest single named category of workplace sickness absence in the country [3], that is not an abstract question. It is the difference between another tool to manage and a system that manages the risk itself.
That is the system we built ALIGN.R3 to be.
Sources
1. Nusca, A. “Nvidia’s Jensen Huang says AI agents are ‘a multi-trillion-dollar opportunity’.” Fortune, 7 January 2025. https://fortune.com/2025/01/07/nvidias-jensen-huang-says-ai-agents-are-a-multi-trillion-dollar-opportunity
2. Altman, S. “The Gentle Singularity.” Personal blog, 10 June 2025. https://blog.samaltman.com/the-gentle-singularity
3. Office for National Statistics. “Sickness absence in the UK labour market: 2025.” Released 1 May 2026. Musculoskeletal problems accounted for 14.6% of sickness absence occurrences, the largest single named condition category; Health and Safety Executive estimates work-related musculoskeletal disorders cost the British economy approximately £7.1bn per year (2023/24).
